Julius S. Ngwa

Julius S. Ngwa

Auto-generated profile, based on publicly available information

Julius S. Ngwa

Developing Brain Institute, Children’s National Hospital, Washington, DC 20010, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2018 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Open access
PDF file
CHChristopher Hübel
Christopher Hübel
Helena GasparHelena Gaspar
Helena Gaspar
Jonathan ColemanJonathan Coleman
Jonathan Coleman
HFHilary Finucane
Hilary Finucane
KPKirstin L. Purves
Kirstin L. Purves
GBGerome Breen
Gerome Breen
Anorexia nervosa (AN) occurs nine times more often in females than in males. Although environmental factors likely play a role, the reasons for this imbalanced sex ratio remain unresolved. AN displays high genetic correlations with anthropometric and metabolic traits. Given sex differences in body composition, we investigated the possible metabolic underpinnings of female propensity for AN. We conducted sex‐specific GWAS in a healthy and medication‐free subsample of the UK Biobank (n = 155,961), identifying 77 genome‐wide significant loci associated with body fat percentage (BF%) and 174 with fat‐free mass (FFM). Partitioned heritability analysis showed an enrichment for central nervous tissue‐associated genes for BF%, which was more prominent in females than males. Genetic correlations of BF% and FFM with the largest GWAS of AN by the Psychiatric Genomics Consortium were estimated to explore shared genomics. The genetic correlations of BF%male and BF%female with AN differed significantly from each other (p < .0001, δ = −0.17), suggesting that the female preponderance in AN may, in part, be explained by sex‐specific anthropometric and metabolic genetic factors increasing liability to AN.

15 November 2025 in Pediatric Radiology
Verified
Journal Article
Open access
PDF file
MJMarin Jacobwitz
Marin Jacobwitz
JNJulius Ngwa
Julius Ngwa
KKKushal Janardan Kapse
Kushal Janardan Kapse
CLCatherine Limperopoulos
Catherine Limperopoulos
NANickie Niforatos Andescavage
Nickie Niforatos Andescavage
Background: In vivo placental volume derived from magnetic resonance imaging (MRI) is a novel imaging tool to evaluate the placenta during pregnancy, as the placenta is difficult to access throughout gestation. There is a paucity of established standardized normative raw values and Z -scores for in vivo placental volume based on MRI. Objective: To establish normative references for in vivo placental MRI-based volumes derived from a large cohort of healthy pregnant women carrying healthy fetuses throughout gestation. Materials and methods: Healthy pregnant women with healthy singleton pregnancies greater than 16 weeks gestation were enrolled in a longitudinal, prospective observational study. In total, 313 placental MRIs were analyzed from 209 pregnant women. In-vivo placentas were manually segmented to derive volumes and Z -scores. Means, standard deviations, and percentiles for normative reference raw values were calculated using weekly gestational age (GA) bins. Placental volume Z -scores were calculated based on 2-week GA bins using means and standard deviations. Results: Normative reference placental volumes from 209 subjects (313 scans) with median GA 31.43 [8.86] weeks are presented in weekly and bi-weekly GA bins. Using 2-week GA intervals, 95% of placental volume Z -scores were within ±2 standard deviations of the population mean. Conclusion: This data provides established normative in vivo raw and Z -score values derived from placental MRI. The value of accessing the placenta in vivo through MRI has become increasingly recognized, as the importance of the placenta in fetal and postnatal health is now more widely known. Establishing normative reference values for the in vivo placenta throughout gestation benefits both the clinical and scientific communities. Graphical

1 May 2021 in JACC
Verified
Journal Article
Closed access
HBHilda Mariana Gonzalez Bonilla
Hilda Mariana Gonzalez Bonilla
NGNitheesha Ganta
Nitheesha Ganta
PAPrince Alebna
Prince Alebna
JNJulius Ngwa
Julius Ngwa
RORichard Ogunti
Richard Ogunti
IOIsaac Opoku-Asare
Isaac Opoku-Asare

10 September 2024 in Placenta
Verified
Journal Article
Closed access
MPMorteza Pishghadam
Morteza Pishghadam
JNJulius S. Ngwa
Julius S. Ngwa
YWYao Wu
Yao Wu
KKKushal Janardan Kapse
Kushal Janardan Kapse
LHLylach Haizler-Cohen
Lylach Haizler-Cohen
NANickie Niforatos Andescavage
Nickie Niforatos Andescavage

28 May 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
KOKatherine Marie Ottolini
Katherine Marie Ottolini
GSGracie Spurney
Gracie Spurney
KWKatherine Leah Wisner
Katherine Leah Wisner
RPRenee Pen
Renee Pen
JNJulius Ngwa
Julius Ngwa
NANickie Niforatos Andescavage
Nickie Niforatos Andescavage
Background/Objectives: Adequate choline intake is critical across the peripartum period for optimal maternal-offspring health. Maternal depressive symptoms are associated with poor dietary quality, but the relationship between postpartum depression and choline intake in lactating mothers of preterm infants, a period of heightened intake requirements, has not been previously explored. Methods: Lactating mothers of hospitalized preterm infants (born ≤36 weeks gestational age) completed depression screening with the Edinburgh Postnatal Depression Scale (EPDS) and a dietary choline intake survey. Mann–Whitney U tests compared maternal choline intake based on EPDS screen status (low-risk or at-risk for depression). Multivariable linear regression assessed the relationship between maternal depressive symptoms and choline intake. Results: EPDS screens were at-risk in 18 (42%) of the 43 participants. Median choline intake across the cohort was <50% of recommended dietary intake (median [IQR] 221 [147, 308] mg), with lower intake in mothers with at-risk EPDS screens compared to low-risk screens (median [IQR] score: 156 [105, 218] mg vs. 298 [196, 357] mg, p < 0.01). In multivariable linear regression, EPDS score was negatively associated with maternal choline intake (β [95% CI] = −0.13 [−0.26, −0.01], p = 0.03). Conclusions: Dietary choline intake is low among lactating mothers of preterm infants, particularly those with postpartum depressive symptoms.

MJMarin Jacobwitz
Marin Jacobwitz
KKKushal Janardan Kapse
Kushal Janardan Kapse
JNJulius Ngwa
Julius Ngwa
JCJosepheen Cruz
Josepheen Cruz
YWYao Wu
Yao Wu
NANickie Niforatos Andescavage
Nickie Niforatos Andescavage
Background: The primary objective of this study was to compare the in vivo placenta volume across gestation in fetuses with congenital heart disease (CHD) and healthy controls. The second objective was to determine the relationship between placental volume and both CHD characteristics and neonatal birth anthropometrics. Methods: Pregnant women with a fetal diagnosis of CHD and healthy pregnancies were enrolled in a longitudinal observational study at Children’s National Hospital. A total of 451 fetal MRIs were analyzed from 284 pregnant women (112 mothers/182 scans with CHD; 172 controls/261 scans). In vivo placentas were manually segmented to derive volumes and z-scores. Z-scores were computed from placental volume data derived from control participants for weekly GA bins using means and standard deviations. Z-scores were then assigned to the CHD cohort. A linear mixed effects model with random intercepts clustered by subject was applied to examine the associations between placental volumes and CHD characteristics, including comparing placental volumes between groups according to gestational windows. Results: Overall, placental volumes in CHD were not significantly different than placental volumes from controls. However, in infants delivered at term age, CHD placental volume plateaued in the final four weeks of gestation. Smaller in vivo CHD placental volume z-scores were associated with decreased weight at delivery (p ≤ 0.0001). Conclusions: This study identifies that in vivo CHD placentas are abnormal in the final four weeks of gestation. Smaller CHD placentas were associated with decreased birth weight, underscoring the importance of placental development in neonatal anthropometrics.